/C O R R E C T I O N -- Privo Technologies/

In the news release, Clinical Update from the Ongoing Phase 2 Trial of PRV111, the First Non-Surgical Therapy in Development for Early-Stage Oral Cancer, issued Oct. 5, 2026 by Privo Technologies over PR Newswire, we are advised by the company that the headline has been updated. The...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.